| PERIOD ENDING | 2-Oct-09 | 3-Apr-09 | 2-Jan-09 | 3-Oct-08 | | Total Revenue | 56,155 | 74,479 | 86,498 | 122,615 | | Cost of Revenue | 22,265 | 35,373 | 40,348 | 56,300 | | | Gross Profit | 33,890 | 39,106 | 46,150 | 66,315 | | | Operating Expenses | | Research Development | 12,568 | 24,468 | 26,313 | 29,279 | | Selling General and Administrative | 13,001 | 18,678 | 19,483 | 21,008 | | Non Recurring | 23,860 | 2,385 | (2,649) | 2,415 | | Others | 429 | 2,885 | 3,371 | 4,455 | | | | Total Operating Expenses | 49,858 | 48,416 | 46,518 | 57,157 | | | | Operating Income or Loss | (3,110) | (9,310) | (368) | 9,158 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 14,428 | 2,423 | (3,141) | (3,352) | | Earnings Before Interest And Taxes | 11,318 | (7,733) | (2,663) | 5,806 | | Interest Expense | 5,514 | 5,930 | 6,054 | 6,852 | | Income Before Tax | 5,804 | (13,663) | (8,717) | (1,046) | | Income Tax Expense | 52 | 341 | 912 | 373 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,747) | (14,839) | (10,475) | (2,227) | | | Non-recurring Events | | Discontinued Operations | 31,203 | 1,083 | (7,214) | 3,144 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 23,456 | (13,756) | (17,689) | 917 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $23,456 | ($13,756) | ($17,689) | $917 |
|
0.02% Nasdaq 
0.33%
Income Statement
